CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 108 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,000 | 0.0% | 1,729 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | -28.6% | 1,729 | -10.4% | 0.00% | -100.0% |
| Q3 2021 | $7,000 | -93.3% | 1,929 | -91.6% | 0.00% | -90.0% |
| Q1 2021 | $104,000 | -25.7% | 22,915 | -6.3% | 0.01% | -33.3% |
| Q4 2020 | $140,000 | +1900.0% | 24,465 | +524.6% | 0.02% | +1400.0% |
| Q4 2019 | $7,000 | -79.4% | 3,917 | -41.5% | 0.00% | -66.7% |
| Q3 2019 | $34,000 | +88.9% | 6,700 | +153.1% | 0.00% | +50.0% |
| Q2 2019 | $18,000 | -88.4% | 2,647 | -77.9% | 0.00% | -84.6% |
| Q1 2018 | $155,000 | – | 11,996 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |